DECREASE EXPRESSION OF BONE MORPHOGENETIC PROTEIN TYPE II RECEPTOR IN SSC TISSUES AND IN ENDOTHELIAL CELLS LEADING TO ENHANCED SUSCEPTIBILITY TO APOPTOSIS